Docetaxel-induced hand foot syndrome: “No dose is a safe dose”

Docetaxel is an important chemotherapeutic agent used in the management of many solid tumors. The most important side effect of this drug is myelosupression. We report a case of carcinoma breast that developed severe hand-foot syndrome at 75 mg/m(2) doses of docetaxel. The exact mechanism of this si...

Descripción completa

Detalles Bibliográficos
Autores principales: Jain, Ankit, Dubashi, Biswajit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356968/
https://www.ncbi.nlm.nih.gov/pubmed/22629102
http://dx.doi.org/10.4103/0976-500X.95534
_version_ 1782233616801071104
author Jain, Ankit
Dubashi, Biswajit
author_facet Jain, Ankit
Dubashi, Biswajit
author_sort Jain, Ankit
collection PubMed
description Docetaxel is an important chemotherapeutic agent used in the management of many solid tumors. The most important side effect of this drug is myelosupression. We report a case of carcinoma breast that developed severe hand-foot syndrome at 75 mg/m(2) doses of docetaxel. The exact mechanism of this side effect in not known. All the physicians using this drug must be aware of this side effect.
format Online
Article
Text
id pubmed-3356968
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-33569682012-05-24 Docetaxel-induced hand foot syndrome: “No dose is a safe dose” Jain, Ankit Dubashi, Biswajit J Pharmacol Pharmacother Case Report Docetaxel is an important chemotherapeutic agent used in the management of many solid tumors. The most important side effect of this drug is myelosupression. We report a case of carcinoma breast that developed severe hand-foot syndrome at 75 mg/m(2) doses of docetaxel. The exact mechanism of this side effect in not known. All the physicians using this drug must be aware of this side effect. Medknow Publications & Media Pvt Ltd 2012 /pmc/articles/PMC3356968/ /pubmed/22629102 http://dx.doi.org/10.4103/0976-500X.95534 Text en Copyright: © Journal of Pharmacology and Pharmacotherapeutics http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Jain, Ankit
Dubashi, Biswajit
Docetaxel-induced hand foot syndrome: “No dose is a safe dose”
title Docetaxel-induced hand foot syndrome: “No dose is a safe dose”
title_full Docetaxel-induced hand foot syndrome: “No dose is a safe dose”
title_fullStr Docetaxel-induced hand foot syndrome: “No dose is a safe dose”
title_full_unstemmed Docetaxel-induced hand foot syndrome: “No dose is a safe dose”
title_short Docetaxel-induced hand foot syndrome: “No dose is a safe dose”
title_sort docetaxel-induced hand foot syndrome: “no dose is a safe dose”
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356968/
https://www.ncbi.nlm.nih.gov/pubmed/22629102
http://dx.doi.org/10.4103/0976-500X.95534
work_keys_str_mv AT jainankit docetaxelinducedhandfootsyndromenodoseisasafedose
AT dubashibiswajit docetaxelinducedhandfootsyndromenodoseisasafedose

Ejemplares similares